1 Merrimack Pharmaceuticals Inc Receivables Turnover Ratio (MACK), from the first quarter 2024 to the first quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Merrimack Pharmaceuticals Inc  (NASDAQ: MACK)
 

Merrimack Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the first quarter 2024 to the first quarter 2023

Quarterly Results, Trends, Rankings, Statistics


According to Merrimack Pharmaceuticals Inc Balance Sheet, in the first quarter 2024, company has not reported any Accounts receivable.
See Merrimack Pharmaceuticals Inc Balance Sheet

If we take a look into Healthcare sector Merrimack Pharmaceuticals Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Merrimack Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MACK Receivables Turnover Ratio (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change - - - - -
Receivable Turnover Ratio (TTM) - - - - -
MACK's Total Ranking # # # # #
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





MACK Company Profile • Back to MACK Efficiency Comparisons • Compare MACK Receivables Turnover Ratio to its Competitors

Financial Statements
Merrimack Pharmaceuticals Inc's Accounts Receivable $ 0 Millions Visit MACK's Balance sheet
Merrimack Pharmaceuticals Inc's Sales TTM $ 0 Millions Visit MACK's Income Statement
Sources of MACK's Revenues Visit MACK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MACK's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MACK's Growth Rates MACK's Roa MACK's Inventory Turnover Ratio MACK's Dividend Comparisons
MACK's Profitability Ratios MACK's Roi MACK's Asset Turnover Ratio MACK's Dividend Growth
MACK's Valuation Ratios MACK's Roe MACK's Financial Strength Ratios MACK's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Receivable at quarter ending Mar 31 2024

Date modified: 2026-09-12T06:14:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.